Medicare’s plan for drug-price negotiation - the importance of defining generic entry

New England Journal of Medicine

8 July 2023 - The Inflation Reduction Act allows CMS to negotiate prices for a small number of Medicare covered drugs. 

Identifying opportunities to proactively address potential gaming of this authority is important.

Read New England Journal of Medicine Perspective

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , US , Regulation , Medicare , Pricing